These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 30516501)
1. [SUBSTANTIATION OF INDICATIONS FOR BIOFEEDBACK THERAPY AND CYTOFLAVIN APPLICATION IN TREATMENT OF OSTEOCHONDROSIS NEUROLOGICAL COMPLICATIONS IN ELDERLY PATIENTS]. Parfenov Y; Vasilevskaya M; Parfenov S; Sapozhnikov K; Kovalenko A; Zaplutanov V Georgian Med News; 2018 Oct; (283):89-96. PubMed ID: 30516501 [TBL] [Abstract][Full Text] [Related]
2. [Peculiarities of clinical and psychophysiological status of elderly patients with osteochondrosis.]. Belov VG; Parfenov YA; Vasilevskaya MA; Parfenov SA; Sapozhnikov KV; Kovalenko AL; Zaplutanov VA Adv Gerontol; 2017; 30(5):757-764. PubMed ID: 29322745 [TBL] [Abstract][Full Text] [Related]
3. [Gerontological trends of contemporary forms of alcohol dependence. Approaches to full compensation and rehabilitation]. Kovalenko AL; Sosin IK; D'iachenko TV; Chuev IuF; Goncharova EIu; Skalyga IM; Kasparevich AIu; Krivosheeva MD Adv Gerontol; 2014; 27(3):553-9. PubMed ID: 25827006 [TBL] [Abstract][Full Text] [Related]
4. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin]. Madzhidova EN; Usmanova DD; Baĭtursunova ZhM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency]. Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033 [TBL] [Abstract][Full Text] [Related]
6. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels]. Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354 [TBL] [Abstract][Full Text] [Related]
7. [Assessment of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome]. Asadullaev MM; Saidvaliev FS; Shermukhamedova FK; Rizvonov ZhK; Vakhabova NM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(10):24-7. PubMed ID: 23250593 [TBL] [Abstract][Full Text] [Related]
8. [Modern methods of energy homeostasis correction in elderly patients]. Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854 [TBL] [Abstract][Full Text] [Related]
9. [Meta-analytic assessment of parenteral cytoflavin effectiveness in different neurologic disorders]. Mazin PV; Sheshunov IV; Mazina NK Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3):28-39. PubMed ID: 28399094 [TBL] [Abstract][Full Text] [Related]
10. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial]. Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615 [TBL] [Abstract][Full Text] [Related]
11. [The effect of the succinic acid preparation on the dynamics of neurological and emotional disturbances in patients with dorsopathy]. Stetsura YA; Sholomov II; Schukovsky NV; Salina EA; Likhacheva EB Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):45-48. PubMed ID: 26120981 [TBL] [Abstract][Full Text] [Related]
12. [The use of cytoflavin for the treatment of chronic brucellosis]. Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446 [TBL] [Abstract][Full Text] [Related]
14. [Antioxidant therapy in discirculatory encephalopathy]. Antipenko EA; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819 [No Abstract] [Full Text] [Related]
15. [The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia]. Drozd OA; Efremov VV; Dudarev IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):46-9. PubMed ID: 23528494 [No Abstract] [Full Text] [Related]
16. [Treatment of alcohol addiction syndrome with cytoflavin]. Belov VG; Parfenov IuA; Okovityĭ SV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6 Pt 2):54-7. PubMed ID: 23887469 [TBL] [Abstract][Full Text] [Related]
17. [Development of an algorithm for the appointment of biofeed-back therapy and Cytoflavin for the treatment of osteochondrosis in elderly patients.]. Parfenov SA; Parfenov YA; Vasilevskaya MA; Kovalenko AL; Elkin AA; Sapozhnikov KV; Rizakhanova OA Adv Gerontol; 2021; 34(3):375-383. PubMed ID: 34409816 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy]. Pochepen' ON Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):23-9. PubMed ID: 21183910 [TBL] [Abstract][Full Text] [Related]
19. [Efficiency of intensive care with cytoflavin in patients of advanced age in combined traumatic brain injury]. Lebedeva EA; Belousova ME; Kurtasov AA; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL Adv Gerontol; 2014; 27(3):578-83. PubMed ID: 25827011 [TBL] [Abstract][Full Text] [Related]
20. [Clinical-encephalographic evaluation of preterm children treated with cytoflavin during the first year of life]. Rogatkina SO; Degtiareva MG; Grebennikova OV; Volodin NN; Sigova IuA; Asmolova GA; Serova ND Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5):16-23. PubMed ID: 21666588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]